Brünner N, Spang-Thomsen M, Vindeløv L, Nielsen A
Br J Cancer. 1983 May;47(5):641-7. doi: 10.1038/bjc.1983.102.
The effect of 17 beta-oestradiol on a "receptor positive" and on a "receptor negative" human breast carcinoma grown in nude mice was studied. Experimental growth data were used to determine the effect on tumour growth. Flow cytometric DNA analysis (FCM) performed on tumour tissue obtained by sequential fine-needle aspirations was used to estimate the effect on the cell cycle. In the receptor-positive breast carcinoma, oestradiol induced complete tumour regression and characteristic cell cycle changes. In the receptor-negative breast carcinoma, no changes in tumour growth and cell cycle distribution could be demonstrated following the treatment. The results indicate that the oestradiol-induced cell kill could be explained to some extent by the induction of polyploid cells, which eventually die. Since the cell cycle changes monitored by FCM in the receptor-positive breast carcinoma appeared prior to any reduction in the tumour size, the results suggest that FCM may prove a valuable method in the early detection of tumour response to hormone treatment in human breast cancer.
研究了17β-雌二醇对在裸鼠体内生长的“受体阳性”和“受体阴性”人乳腺癌的影响。实验生长数据用于确定对肿瘤生长的影响。对通过连续细针穿刺获得的肿瘤组织进行流式细胞术DNA分析(FCM),以评估对细胞周期的影响。在受体阳性乳腺癌中,雌二醇诱导肿瘤完全消退并伴有特征性细胞周期变化。在受体阴性乳腺癌中,治疗后未观察到肿瘤生长和细胞周期分布的变化。结果表明,雌二醇诱导的细胞杀伤在一定程度上可以通过诱导多倍体细胞来解释,这些多倍体细胞最终会死亡。由于在受体阳性乳腺癌中通过FCM监测到的细胞周期变化在肿瘤大小任何减小之前就已出现,结果表明FCM可能是早期检测人乳腺癌对激素治疗反应的一种有价值的方法。